Tina-Thien Ho pursued her pharmaceutical degree at the Free University of Berlin (Germany), where the conveyed substantiated knowledge allowed her to pass the second section of the pharmaceutical state exam.
During her studies, she applied her competencies in the department of quality assurance at Berlin-Chemie AG, where she was part of a project team for establishing new evaluation procedures of in-process control data. Her work involved cross referencing and analyzing potential anomalies in order to detect root causes to existing or hidden problems, thus improving the overall process performance.
In addition, she performed an internal placement in the department of quality control at Berlin-Chemie AG where she took the responsibility for establishing classical microchemical test methods to detect and identify selected cations as contaminants in incoming goods.
She was awarded a fellowship by ERASMUS and upon graduation she went on to pursue an internship at the Karolinska Institutet (KI) in Stockholm, Sweden. There her research project involved working with synthetic oligonucleotides in order to optimize an oligonucleotide-based purification method for Frataxin-expressing minicircles that can be used as a therapy approach for Friedreich’s Ataxia.
Whilst based in Stockholm, she entered KI’s Co-Up Lab programme operated by EIT Health, in which she was directly confronted with the entrepreneurial spirit to foster innovation within the medical field.
| Host institution | University of Southampton, School of Chemistry, Southampton, UK |
| Supervisor | Prof. Eugen Stulz |
| Co-Supervisors | Prof. Philippe Barthélémy, University of Bordeaux INSERM U1212 / UMR CNRS 5320, Bordeaux, France (Academic) |
| Dr. Anna Perdrix Rosell, Sixfold Bioscience, London, UK (Industrial) |